Nucleophosmin/B23, a multifunctional protein that can regulate apoptosis.

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• Nucleophosmin (NPM)/B23 is a multifunctional nucleolar protein overexpressed in proliferating and cancer cells.
• NPM/B23 acts as a tumor marker, promoting oncogenesis by suppressing tumor suppressors.
• The aberrant NPM-ALK fusion protein in anaplastic large cell lymphoma (ALCL) contributes to lymphomagenesis.

Purpose of the Study:

• To elucidate the direct role of NPM/B23 in inhibiting apoptosis.
• To investigate the mechanism by which NPM/B23 mediates anti-apoptotic effects.
• To identify potential therapeutic targets in NPM/B23 amplified cancers.

Main Methods:

• Identification of NPM/B23 as a nuclear PI(3,4,5)P3 binding protein using a PI(3,4,5)P3 column and NGF-treated PC12 nuclear extracts.
• Assessment of NPM/B23's role in mediating anti-apoptotic effects of NGF by inhibiting DNA fragmentation activity of Caspase-Activated DNase (CAD).
• Utilizing NPM/B23 mutants unable to associate with PI(3,4,5)P3 to study complex formation and function.

Main Results:

• NPM/B23 directly binds to nuclear PI(3,4,5)P3, forming a complex that inhibits DNA fragmentation.
• NPM/B23 mediates the anti-apoptotic effects of Nerve Growth Factor (NGF) by preventing CAD-mediated DNA fragmentation.
• NPM/B23 mutants deficient in PI(3,4,5)P3 binding failed to inhibit DNA fragmentation, confirming the complex's role.

Conclusions:

• The PI(3,4,5)P3/NPM/B23 complex plays a crucial role in regulating nuclear anti-apoptotic activity.
• NPM/B23's ability to inhibit apoptosis via PI(3,4,5)P3 binding presents a novel therapeutic strategy.
• Targeting the anti-apoptotic action of NPM/B23 offers a promising avenue for treating NPM/B23 amplified cancers.